Joana Zacarias

Prof. Dr. Joana Zacarias

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
JZJoana Zacarias
Joana Zacarias
JAJosiane Bazzo de Alencar
Josiane Bazzo de Alencar
PTPatrícia Yumeko Tsuneto
Patrícia Yumeko Tsuneto
VSVictor Souza
Victor Souza
CSCléverson O. Silva
Cléverson O. Silva
ASAna Sell
Ana Sell
The pathogenesis of periodontitis involves a complex interaction between the microbial challenge and the host immune response. The individual immunoinflammatory response has a great contribution in the pathogenesis of the disease and becomes a trigger in the process of bone remodeling which is a characteristic of the disease. Thus, the aim of this study was to evaluate the influence of theTLR4A896G (rs4986790),TLR4C1196T (rs4986791),CD14C-260T (rs2569190),RANKL(TNFSF11, rs2277438), andOPG(TNFSF11BC163T, rs3102735) polymorphisms in periodontitis. A case-control study was conducted on patients with periodontitis (N=203) and controls (N=213) over 30 years of age, without diabetes mellitus, acute infections, and osteoarthritis, and patients without aggressive periodontitis, i.e., stage IV and C degree of periodontitis, and any periodontal treatment performed in the last 6 months. Genotypes were determined by the PCR-RFLP and sequencing method. The frequency comparisons between case and controls were performed using the chi-square test and logistic regression (OpenEpi and SNPStats software). The risk (OR) was evaluated for values ofP<0.05. Differences inTLR4,CD14,RANKL, andOPGgenotype and allele frequency distributions were not observed between patients and controls. However, some variants were a risk factor for the development of periodontitis when considering gender and smoking habits. TheTLR4896 A/G genotype was a risk factor for periodontitis in males (OR=2.86), and theTLR41196C/C genotype was a risk factor for nonsmoking males (OR=1.85) when compared to women. TheRANKLA/A and theOPGT/C genotype was associated with the risk of the disease in nonsmoking men compared to nonsmoking women with the same genotype (OR=1.96andOR=2.9, respectively). In conclusion,TLR4,CD14,RANKL, andOPGvariants were not associated with periodontitis. However,TLR4,RANKL, andOPGpolymorphisms could be a risk for periodontitis in males regardless of smoking habits.

1 April 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
PTPatrícia Yumeko Tsuneto
Patrícia Yumeko Tsuneto
VSVictor Souza
Victor Souza
JAJosiane Bazzo de Alencar
Josiane Bazzo de Alencar
JZJoana Zacarias
Joana Zacarias
CSCléverson O. Silva
Cléverson O. Silva
ASAna Sell
Ana Sell
Genetic variations contribute to the susceptibility in the development of periodontitis. The aim of this study was to investigate the influence of IL18, IL12, and MMP9 polymorphisms in the chronic periodontitis. This case-control study involved 381 individuals matched by gender and age. Genotyping of IL18 (rs187238 and rs1946518) and IL12B (rs3212227) was performed by PCR-SSP and PCR-RFLP was used for MMP9 (rs3918242). IL-18 and MMP-9 were quantified in the serum by ELISA. SNPStats and OpenEpi software were used for statistical analysis and, in order to eliminate smoking as a confounding factor, the analyses were also performed in nonsmoking subjects. The IL18-137G/C genotype was associated with the risk of chronic periodontitis in nonsmokers (Pc=0.03; OR=1.99; overdominant inherence model). In the multivariate analyses, homozygous IL18-137G/G and IL18-607C/C were more frequent in males compared to women with these same genotypes (OR=2.51 and OR=3.30, respectively). The serum levels of the IL-18 in patients were higher than those in healthy controls (P=0.005). IL12B and MMP9 polymorphisms and MMP-9 serum concentration were similar in patients and controls. In this study, IL18 was associated with chronic periodontitis susceptibility. Men had greater risk than women for developing the disease when IL18 polymorphism was considered and the susceptibility was independent of the smoking status.

8 December 2020 in International Journal of Inflammation
Verified
Journal Article
Open access
PDF file
JNJanisleya Silva Ferreira Neves
Janisleya Silva Ferreira Neves
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
DRDenise Manjurma da Silva Reis
Denise Manjurma da Silva Reis
MLMarco Antonio Rocha Loures
Marco Antonio Rocha Loures
HAHugo Vicentin Alves
Hugo Vicentin Alves
ASAna Sell
Ana Sell
Spondyloarthritis (SpA) is an inflammatory rheumatic disease related to low bone mineral density. Because vitamin D plays an important role in bone metabolism and immune system modulation, the aim of this study was to evaluate the influence of polymorphisms in vitamin D receptor genes (VDR) in the development of SpA. In this case–control study, a total of 244 patients with SpA and 197 individuals with no SpA were included. Among the patients, 174 had ankylosing spondylitis (AS) and 66 had psoriatic arthritis (PsA). Genotyping of FokI (rs2228570 C > T), BsmI (rs1544410 C > T), ApaI (rs7975232 A > C), and TaqI (rs731236 T > C) was performed using PCR-RFLP, while genotyping of HLA-B27 was performed using PCR-SSP. Serum levels for hydroxy (OH) vitamin D and the clinical activity index of the disease (BASDAI) were also evaluated. SNPStats and OpenEpi software were used for statistical analysis. The ApaI a allele and ApaI a/a genotype were less frequent in PsA compared with controls. The ApaI a/a genotype was associated with a protecting factor for PsA in females, and ApaI A/a was associated with a protecting factor for the disease in HLA-B27 positive patients. Notwithstanding, the ApaI a/a genotype was a risk factor for SpA and AS in males. The FokI f/f genotype was associated with a better clinical activity in PsA. When considering the covariates, vitamin D sufficiency, and gender, the FokI F/F genotype was associated with a risk factor in males with SpA and AS compared with females with this same genotype. In conclusion, the ApaI rs7975232 polymorphism was associated with PsA, and the FokI rs2228570 polymorphism was associated with better clinical PsA activity. ApaI and FokI were associated with SpA and AS when considering gender and vitamin D sufficiency.

1 December 2016 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
JZJoana Zacarias
Joana Zacarias
ILIeda Bernadete Volkweis Langer
Ieda Bernadete Volkweis Langer
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
ASAna Sell
Ana Sell

Verified
Journal Article
Open access
PDF file
JNJanisleya Neves
Janisleya Neves
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
DRDenise Manjurma da Silva Reis
Denise Manjurma da Silva Reis
MLMarco Antonio Rocha Loures
Marco Antonio Rocha Loures
HAHugo Vicentin Alves
Hugo Vicentin Alves
ASAna Sell
Ana Sell
HLA-B*27 is an important marker for spondyloarthritis (SpA), however, many SpA patients are HLA-B*27 negative. Thus, the aim of this study was to investigate the influence of IL17, TNF and VDR gene polymorphisms in SpA patients who were HLA-B*27 negative. This case-control study was conducted in 158 patients [102 patients with ankylosing spondylitis (AS) and 56 with psoriatic arthritis (PsA)] and 184 controls. HLA-B*27 genotyping was performed using PCR-SSP and IL17A (rs2275913), IL17F (rs763780), TNF-308 (rs1800629), TNF-238 (rs361525), FokI C>T (rs2228570), TaqI C>T (rs731236), ApaI A>C (rs7975232), and BsmI C>T (rs1544410) using PCR-RFLP. Statistical analyses were performed by Chi-square and logistic regression using OpenEpi and SNPStats software. The IL17F C allele frequency was higher in patients with SpA, AS and PsA compared to controls. The IL17F T/C genotype frequency was higher in SpA patients in an overdominant inheritance model and when men and women were separately analyzed. IL17A_IL17F AC haplotype was significantly associated to the risk for SpA patients. As for VDR, the ApaI a/a was a potential risk factor for SpA in men. In conclusion, IL17F C variant contributed to the risk of SpA in Brazilian patients who were HLA-B*27 negative and could be a potential marker for SpA.

1 August 2016 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
JZJoana Zacarias
Joana Zacarias
EPElizangela Mendes de Figueiredo Pereira
Elizangela Mendes de Figueiredo Pereira
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
GGGláucia Andréia Soares Guelsin
Gláucia Andréia Soares Guelsin
FMFabiano Cavalcante de Melo
Fabiano Cavalcante de Melo
ASAna Sell
Ana Sell